The PLOD2 gene helps collagen, the body’s main support protein, form strong links in bone, cartilage, and other connective tissues. When this gene does not work properly, those tissues can be less stable, which may lead to fragile bones, repeated fractures, joint stiffness or contractures, short stature, and curvature of the spine. Pathogenic variants in both copies of the PLOD2 gene are linked to Bruck syndrome type 2, a condition that affects bone strength and movement.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, which are the parts of cells that do the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To explore this subject in greater detail, you can learn more in the LearnHub.
Overview
PLOD2Gene function
What if the gene works
The PLOD2 gene helps cells modify collagen so it forms strong, stable fibers. This supports the normal structure of bone, cartilage, and other connective tissues.
Risk
What if the gene does not work
Variants in the PLOD2 gene can cause Bruck syndrome type 2, linked to fragile bones and joints that are stiff from birth. Milder or more severe variants may affect when problems appear and how marked they are.
Treatment
What does that mean for your treatment
No treatment approach tied specifically to the PLOD2 gene is currently established for people with a pathogenic or loss-of-function variant in the PLOD2 gene. The PLOD2 gene is also being studied as a biomarker and possible drug target in some cancers and fibrotic conditions.
Conditions associated with PLOD2
Gene function
What if the gene works
Bone, cartilage, skin, and other connective tissues depend on collagen that is finished correctly inside the cell. The PLOD2 gene supports this finishing process so collagen fibers can be built with the right strength and structure. In everyday terms, it helps your body make connective tissue that can handle pulling, bending, and support.
Inside collagen-making cells, the PLOD2 gene adds a small chemical tag to selected lysine building blocks in collagen. This is a normal step in preparing collagen before it is released outside the cell.
These chemical tags allow collagen strands to form strong links with one another after they are assembled. That linking helps create collagen fibers that are more organized and better able to support tissue shape.
By helping collagen mature properly, the PLOD2 gene supports the body’s connective tissue framework. This is part of what the PLOD2 gene does in connective tissue throughout bones, cartilage, tendons, ligaments, and skin.
What is a variant?
A genetic variant is a slight alteration in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PLOD2 gene can alter the lysyl hydroxylase 2 enzyme so collagen is less completely processed and forms weaker cross-links within the tissue matrix. In simple terms, this is how PLOD2 gene variants affect collagen at the cellular level. Milder variants may leave some enzyme activity, while more severe variants can make the protein unstable, trapped inside the cell, or absent. That difference can influence how early and how strongly Bruck syndrome features appear.
How variants are linked to conditions
Pathogenic variants in the PLOD2 gene cause Bruck syndrome type 2, a rare inherited condition with fragile bones, repeated fractures, and joint contractures present from birth or early childhood. In day to day life, this can mean a child has frequent broken bones along with stiffness in larger joints. When testing finds two disease-causing changes, it can confirm a PLOD2 gene Bruck syndrome type 2 diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant tied to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PLOD2, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having a PLOD2-related condition is higher when both parents carry a harmful change in the PLOD2 gene, especially in families with a known history of the condition.
Inheritance of PLOD2 variants
For families asking about the PLOD2 inheritance pattern, the best established PLOD2-related condition is inherited in an autosomal recessive way. This means a person usually inherits one PLOD2 variant from each parent, and parents who each carry one variant are often unaffected themselves. With each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. Because the PLOD2 gene is on an autosome, this pattern is the same for males and females.
What does my PLOD2 result mean for my family?
For families with a disease-causing change in the PLOD2 gene, the pattern is usually recessive, which means parents can be healthy carriers while a child is affected. Brothers and sisters may also be affected or be carriers, and relatives planning children may want to learn whether they carry the same gene change. The family impact depends on the exact result found in your family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PLOD2 variants usually uses a blood or saliva sample to read the PLOD2 gene and look for changes linked to inherited connective tissue conditions. Testing may be done as a single gene test, as part of a panel, or through exome sequencing. Results can identify a relevant variant, show none, or find a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the PLOD2 gene may be worth considering when someone has repeated fractures starting in childhood, stiff or contracted joints at birth, or other signs of a rare bone and connective tissue condition linked to this gene. It can also help when there is a family history of the condition or when both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, how the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to drugs differently. These differences are common and can influence both how effective a medicine feels and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect a person’s response to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how the body processes a drug and how strongly it works. This information can help support treatment decisions that are better informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the PLOD2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or your health are best discussed with your doctor.
History
PLOD2 entered the scientific literature as researchers worked out how collagen is built and strengthened in the body. In the 1990s, it was identified as one of the lysyl hydroxylase genes, helping separate closely related genes that had previously been studied together. From these first observations, research expanded steadily. Investigators later linked variants in the PLOD2 gene to inherited bone and connective tissue conditions, especially Bruck syndrome, which gave the gene clearer clinical importance. Over time, PLOD2 also drew attention in fibrosis and cancer research because altered activity was seen in scarred and tumor tissue. The way this gene was viewed has shifted over time, from a basic collagen research finding to a gene with recognized medical relevance.